Literature DB >> 31792459

Prenatal androgen exposure and transgenerational susceptibility to polycystic ovary syndrome.

Sanjiv Risal1, Yu Pei1,2, Haojiang Lu1, Maria Manti1, Romina Fornes1, Han-Pin Pui1, Zhiyi Zhao1,3, Julie Massart4, Claes Ohlsson5, Eva Lindgren1, Nicolas Crisosto6,7, Manuel Maliqueo6, Barbara Echiburú6, Amanda Ladrón de Guevara6, Teresa Sir-Petermann6, Henrik Larsson8,9, Mina A Rosenqvist8, Carolyn E Cesta10, Anna Benrick11,12, Qiaolin Deng13,14, Elisabet Stener-Victorin15.   

Abstract

How obesity and elevated androgen levels in women with polycystic ovary syndrome (PCOS) affect their offspring is unclear. In a Swedish nationwide register-based cohort and a clinical case-control study from Chile, we found that daughters of mothers with PCOS were more likely to be diagnosed with PCOS. Furthermore, female mice (F0) with PCOS-like traits induced by late-gestation injection of dihydrotestosterone, with and without obesity, produced female F1-F3 offspring with PCOS-like reproductive and metabolic phenotypes. Sequencing of single metaphase II oocytes from F1-F3 offspring revealed common and unique altered gene expression across all generations. Notably, four genes were also differentially expressed in serum samples from daughters in the case-control study and unrelated women with PCOS. Our findings provide evidence of transgenerational effects in female offspring of mothers with PCOS and identify possible candidate genes for the prediction of a PCOS phenotype in future generations.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31792459     DOI: 10.1038/s41591-019-0666-1

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  62 in total

1.  Anogenital distance in newborn daughters of women with polycystic ovary syndrome indicates fetal testosterone exposure.

Authors:  E S Barrett; K M Hoeger; S Sathyanarayana; D H Abbott; J B Redmon; R H N Nguyen; S H Swan
Journal:  J Dev Orig Health Dis       Date:  2018-01-09       Impact factor: 2.401

Review 2.  Early developmental conditioning of later health and disease: physiology or pathophysiology?

Authors:  M A Hanson; P D Gluckman
Journal:  Physiol Rev       Date:  2014-10       Impact factor: 37.312

Review 3.  Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome.

Authors:  Daniel A Dumesic; Sharon E Oberfield; Elisabet Stener-Victorin; John C Marshall; Joop S Laven; Richard S Legro
Journal:  Endocr Rev       Date:  2015-10       Impact factor: 19.871

4.  Prenatal androgen exposure programs metabolic dysfunction in female mice.

Authors:  Alison V Roland; Craig S Nunemaker; Susanna R Keller; Suzanne M Moenter
Journal:  J Endocrinol       Date:  2010-08-16       Impact factor: 4.286

5.  Are there any sensitive and specific sex steroid markers for polycystic ovary syndrome?

Authors:  Elisabet Stener-Victorin; Göran Holm; Fernand Labrie; Lars Nilsson; Per Olof Janson; Claes Ohlsson
Journal:  J Clin Endocrinol Metab       Date:  2009-12-16       Impact factor: 5.958

6.  Maternal testosterone exposure increases anxiety-like behavior and impacts the limbic system in the offspring.

Authors:  Min Hu; Jennifer Elise Richard; Manuel Maliqueo; Milana Kokosar; Romina Fornes; Anna Benrick; Thomas Jansson; Claes Ohlsson; Xiaoke Wu; Karolina Patrycja Skibicka; Elisabet Stener-Victorin
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-02       Impact factor: 11.205

7.  The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria.

Authors:  Wendy A March; Vivienne M Moore; Kristyn J Willson; David I W Phillips; Robert J Norman; Michael J Davies
Journal:  Hum Reprod       Date:  2009-11-12       Impact factor: 6.918

8.  Testosterone is associated with insulin resistance index independently of adiposity in women with polycystic ovary syndrome.

Authors:  Kari Luotola; Terhi T Piltonen; Johanna Puurunen; Laure C Morin-Papunen; Juha S Tapanainen
Journal:  Gynecol Endocrinol       Date:  2017-07-05       Impact factor: 2.260

9.  PCOS in 2015: New insights into the genetics of polycystic ovary syndrome.

Authors:  Ricardo Azziz
Journal:  Nat Rev Endocrinol       Date:  2016-01-29       Impact factor: 43.330

10.  AKR1C3-Mediated Adipose Androgen Generation Drives Lipotoxicity in Women With Polycystic Ovary Syndrome.

Authors:  Michael W O'Reilly; Punith Kempegowda; Mark Walsh; Angela E Taylor; Konstantinos N Manolopoulos; J William Allwood; Robert K Semple; Daniel Hebenstreit; Warwick B Dunn; Jeremy W Tomlinson; Wiebke Arlt
Journal:  J Clin Endocrinol Metab       Date:  2017-09-01       Impact factor: 5.958

View more
  62 in total

1.  Characterization of Metabolic Patterns in Mouse Oocytes during Meiotic Maturation.

Authors:  Ling Li; Shuai Zhu; Wenjie Shu; Yueshuai Guo; Yusheng Guan; Juan Zeng; Haichao Wang; Longsen Han; Jiaqi Zhang; Xiaohui Liu; Chunling Li; Xiaojing Hou; Min Gao; Juan Ge; Chao Ren; Hao Zhang; Tim Schedl; Xuejiang Guo; Minjian Chen; Qiang Wang
Journal:  Mol Cell       Date:  2020-10-16       Impact factor: 17.970

2.  Current concepts of polycystic ovary syndrome pathogenesis.

Authors:  Robert L Rosenfield
Journal:  Curr Opin Pediatr       Date:  2020-10       Impact factor: 2.856

Review 3.  Epigenetic Transgenerational Inheritance of Obesity Susceptibility.

Authors:  Stephanie E King; Michael K Skinner
Journal:  Trends Endocrinol Metab       Date:  2020-03-24       Impact factor: 12.015

Review 4.  Animal Models to Understand the Etiology and Pathophysiology of Polycystic Ovary Syndrome.

Authors:  Elisabet Stener-Victorin; Vasantha Padmanabhan; Kirsty A Walters; Rebecca E Campbell; Anna Benrick; Paolo Giacobini; Daniel A Dumesic; David H Abbott
Journal:  Endocr Rev       Date:  2020-07-01       Impact factor: 19.871

5.  A primate perspective on oocytes and transgenerational PCOS.

Authors:  Daniel A Dumesic; Jennifer R Wood; David H Abbott; Jerome F Strauss
Journal:  Reprod Biomed Online       Date:  2020-03-07       Impact factor: 3.828

6.  Novel PGK1 determines SKP2-dependent AR stability and reprograms granular cell glucose metabolism facilitating ovulation dysfunction.

Authors:  Xia Liu; Changfa Sun; Kexin Zou; Cheng Li; Xiaojun Chen; Hangchao Gu; Zhiyang Zhou; Zuwei Yang; Yaoyao Tu; Ningxin Qin; Yiran Zhao; Yimei Wu; Yicong Meng; Guolian Ding; Xinmei Liu; Jianzhong Sheng; Chuanjin Yu; Hefeng Huang
Journal:  EBioMedicine       Date:  2020-10-21       Impact factor: 8.143

Review 7.  Epigenetic inheritance of polycystic ovary syndrome - challenges and opportunities for treatment.

Authors:  Elisabet Stener-Victorin; Qiaolin Deng
Journal:  Nat Rev Endocrinol       Date:  2021-07-07       Impact factor: 43.330

8.  Roles of the Notch Signaling Pathway in Ovarian Functioning.

Authors:  Shuhan Guo; Song Quan; Siyi Zou
Journal:  Reprod Sci       Date:  2021-05-18       Impact factor: 3.060

Review 9.  Polycystic Ovary Syndrome: Ontogeny in Adolescence.

Authors:  Christine M Burt Solorzano; Christopher R McCartney
Journal:  Endocrinol Metab Clin North Am       Date:  2021-01-11       Impact factor: 4.741

10.  Abnormal GnRH Pulsatility in Polycystic Ovary Syndrome: Recent Insights.

Authors:  Christopher R McCartney; Rebecca E Campbell
Journal:  Curr Opin Endocr Metab Res       Date:  2020-04-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.